Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

Share Price Information for Mandarin In.sg (MDO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.06
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.06
MDO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

10 Nov 2022 09:42

RNS Number : 9939F
Mandarin Oriental International Ltd
10 November 2022
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

10th November 2022 - Mandarin Oriental International Limited today issues its Interim Management Statement for the third quarter of 2022.

 

The return of normal travel conditions in most of the world in early 2022 saw the Group record net underlying profits (unaudited) in the second quarter, and this progress continued in the third quarter.

 

In the Group's owned hotels, improvements in occupancy and high rates resulted in a stronger performance in the third quarter. This drove increased profitability compared to the second quarter, particularly in Paris and Munich. Two of the Group's key profit-generating hotels, in Hong Kong and Tokyo, however, remained subject to stringent travel restrictions throughout the third quarter, which significantly impacted operating performance. The hotels in Bangkok and Singapore continued their recovery following the removal of travel barriers.

 

The performance of the management business was strong in the third quarter and it recorded a significant improvement in profitability compared to the second quarter. Of particular note were the contributions made by a number of the Group's Mediterranean and Middle Eastern properties.

 

As a result of the improved trading conditions and Mandarin Oriental's expanded portfolio of hotels and residences, the Group recorded its highest quarterly EBITDA since 2019. Both the owned hotels and the management business delivered higher EBITDA than in the second quarter of 2022.

 

In September 2022, the Group opened Mandarin Oriental Palace, Luzern, its second hotel in Switzerland, and its standalone residences project in Barcelona. Recently, the Group announced a new hotel in Tianfu, the new business district of Chengdu, further expanding its presence in China. On 8th September 2022, the Group completed the sale of Mandarin Oriental, Washington D.C., for US$139 million. As a result, the Group has recognised a post-tax, non-trading gain in the third quarter of US$47 million.

 

Following the disposal, net debt at 30th September 2022 reduced to US$385 million (US$519 million at 30th June 2022), and the Group held US$267 million of cash reserves and US$472 million in available, committed debt facilities. Gearing was 8% of adjusted shareholders' funds.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the standard segment of the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

Mandarin Oriental Hotel Group International Limited

James Riley

(852) 2895 9288

Matthew Bishop

(852) 2895 9288

Brunswick Group Limited

William Brocklehurst

(852) 5685 9881

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKBLBFLFLXFBK
Date   Source Headline
3rd Jul 201411:15 amRNSNotice of 2014 Half-Yearly Results
11th Jun 201411:00 amRNSHolding(s) in Company
30th May 201410:08 amRNSTotal Voting Rights
27th May 20149:47 amRNSTransfer of Listing Segment
7th May 20142:21 pmRNSNon-Routine Resolutions submitted via NSM
7th May 20142:08 pmRNSResult of AGM
7th May 201412:33 pmRNSInterim Management Statement
30th Apr 201410:08 amRNSTotal Voting Rights
29th Apr 201411:07 amRNSDirector/PDMR Shareholding
29th Apr 201410:37 amRNSDividend
24th Apr 201411:32 amRNSTransfer of Listing Segment
23rd Apr 201411:54 amRNSDirector/PDMR Shareholding
22nd Apr 201412:02 pmRNSDirector/PDMR Shareholding
8th Apr 20142:55 pmRNSResult of Special General Meeting
3rd Apr 201410:16 amRNSAnnual Financial Report
26th Mar 20147:00 amRNSMO to Expand Mandarin Oriental, Munich
25th Mar 20149:12 amRNSBlocklisting Interim Review
14th Mar 201410:49 amRNSDirector/PDMR Shareholding
12th Mar 201411:34 amRNSDirector Declaration
6th Mar 20149:51 amRNSPublication of Shareholder Circular
6th Mar 20149:17 amRNSFinal Results
6th Mar 20149:10 amRNSPropose Transfer of Listing Segment
10th Feb 20149:21 amRNSNotice of 2013 Final Results
31st Dec 20138:01 amRNSTotal Voting Rights
29th Nov 20139:58 amRNSTotal Voting Rights
6th Nov 20139:10 amRNSInterim Management Statement
31st Oct 201311:18 amRNSTotal Voting Rights
2nd Oct 201310:21 amRNSDividend
30th Sep 201310:13 amRNSTotal Voting Rights
25th Sep 201310:18 amRNSBlocklisting Interim Review
10th Sep 201310:54 amRNSDirector/PDMR Shareholding
2nd Sep 201312:19 pmRNSDirector/PDMR Shareholding
1st Aug 201310:06 amRNSHalf Yearly Report
4th Jul 201310:42 amRNSNotice of 2013 Half-Yearly Results
2nd Jul 201310:24 amRNSTotal Voting Rights
31st May 201310:43 amRNSTotal Voting Rights
31st May 201310:42 amRNSDirector Declaration
15th May 20133:27 pmRNSResult of AGM
15th May 20132:15 pmRNSResult of AGM
15th May 201312:35 pmRNSInterim Management Statement
8th May 201310:25 amRNSDividend
30th Apr 201312:05 pmRNSDirector Declaration
15th Apr 201310:14 amRNSAnnual Financial Report
2nd Apr 201310:54 amRNSTotal Voting Rights
27th Mar 20139:40 amRNSDirector Declaration
25th Mar 201310:13 amRNSBlocklisting Interim Review
20th Mar 20138:44 amRNSAdditional Listing
19th Mar 201310:45 amRNSDirector/PDMR Shareholding
18th Mar 201311:21 amRNSDirector/PDMR Shareholding
13th Mar 201312:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.